A61K 47/6901
Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral
Official title: {Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors}
A61K47/6901 (Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral) appears on 672 US grants and 1,193 published applications in this corpus.
Search patents in A61K- Granted patents
- 672
- Published applications
- 1,193
- Assignees
- 592
- Inventors
- 2,256
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 15 | 0 |
| 1998 | 12 | 0 |
| 1999 | 11 | 0 |
| 2000 | 19 | 0 |
| 2001 | 14 | 5 |
| 2002 | 14 | 31 |
| 2003 | 19 | 37 |
| 2004 | 16 | 39 |
| 2005 | 14 | 31 |
| 2006 | 18 | 33 |
| 2007 | 9 | 42 |
| 2008 | 11 | 36 |
| 2009 | 16 | 31 |
| 2010 | 17 | 32 |
| 2011 | 23 | 44 |
| 2012 | 17 | 36 |
| 2013 | 30 | 35 |
| 2014 | 20 | 32 |
| 2015 | 33 | 36 |
| 2016 | 18 | 39 |
| 2017 | 22 | 29 |
| 2018 | 25 | 57 |
| 2019 | 47 | 73 |
| 2020 | 41 | 75 |
| 2021 | 23 | 67 |
| 2022 | 36 | 68 |
| 2023 | 28 | 57 |
| 2024 | 33 | 73 |
| 2025 | 29 | 78 |
| 2026 | 23 | 77 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treating vasculature related diseases or disorders using nanoparticles29 Sep 2026US 12,746,212 B2The Regents of the University of California
- Sugar derived lipid nanomaterials and uses thereof15 Sep 2026US 12,735,427 B2Ohio State Innovation Foundation
- Cell-penetrating peptides15 Sep 2026US 12,735,468 B2Fundació Hospital Universitari Vall D'Hebron—Institut De Recerca
- Compositions comprising a tweak ligand and methods of using same25 Aug 2026US 12,714,740 B2Children's Hospital Medical Center
- Methods of making targeted vesicles, and compositions made thereby18 Aug 2026US 12,708,670 B2University of Georgia Research Foundation, Inc.
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Process for purifying red blood cell membrane fragments8 Oct 2026US 2026/0306656 A1Ohio State Innovation Foundation
- Compositions and methods for treatment of systemic lupus erythematosus1 Oct 2026US 2026/0295001 A1
- Chimeric polypeptides, extracellular vesicles comprising the same, and uses thereof1 Oct 2026US 2026/0295068 A1Ciloa
- Modified aav vectors for gene therapy1 Oct 2026US 2026/0295079 A1The Trustees of Indiana University
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Conjugates for introducing nucleic acid into higher eucaryotic cells213US 5,521,291 ABoehringer Ingelheim International GmbH · 1996
- Polymeric encapsulation system promoting angiogenesis152US 6,383,478 B1Vanderbilt University · 2002
- Redirection of cellular immunity by receptor chimeras135US 7,049,136 B2The General Hospital Corporation · 2006
- Cleavage of targeted RNA by RNAase P108US 5,168,053 AYale University · 1992